Ivermectin for COVID-19: real-time meta analysis of 63 studies


Authors: Covid Analysis, Aug 12, 2021, Version 109 — twitter personality response, added Together Trial (V1 Nov 26, 2020) •Meta analysis using the most serious outcome reported shows 73% and 86% improvement for early treatment and…[...]

New Covid-19 Hospitalizations for 30- to 39-Year-Olds at Record Rate


Group largely avoided hospitals earlier in pandemic, but highly contagious Delta variant and lagging vaccination rates have changed health outcomes Authors: By Melanie Evans and Taylor Umlauf Hospitalizations of Covid-19 patients in their…[...]

Trained Innate Immunity, Epigenetics, and Covid-19


Authors: Alberto Mantovani, M.D., and Mihai G. Netea, M.D. Innate immunity is mediated by different cell types and cell-associated or fluid-phase pattern-recognition molecules and plays a key role in tissue repair…[...]

Good news: Mild COVID-19 induces lasting antibody protection


People who have had mild illness develop antibody-producing cells that can last lifetime Authors: by Tamara Bhandari•May 24, 2021 Months after recovering from mild cases of COVID-19, people still have immune…[...]

COVID-19 Science Update released: June 4, 2021 Edition 92


Authors: From the Office of the Chief Medical Officer, CDC COVID-19 Response, and the CDC Library, Atlanta GA. Intended for use by public health professionals responding to the COVID-19 pandemic. PEER-REVIEWED…[...]

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans


Authors: Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, Charles W. Goss, Adriana M. Rauseo, Aaron J. Schmitz, Lena Hansen, Alem Haile, Michael K. Klebert, Iskra Pusic, Jane A. O’Halloran, Rachel M. Presti & Ali H. Ellebedy  Abstract Long-lived bone marrow plasma cells (BMPCs)…[...]